Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with or without electroconvulsive therapy (ECT). T...
Saved in:
Main Authors: | Courtney M. Vecera (Author), Alan C. Courtes (Author), Gregory Jones (Author), Jair C. Soares (Author), Rodrigo Machado-Vieira (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GABA And Glutamate New Developments In Neurotransmission Research
Published: (2018) -
The effects of physical activity on glutamate neurotransmission in neuropsychiatric disorders
by: Richard Baskerville, et al.
Published: (2023) -
Glutamate and GABA in vestibulo-sympathetic pathway neurons
by: Gay R Holstein, et al.
Published: (2016) -
Developmental Changes of Glutamate and GABA Receptor Densities in Wistar Rats
by: Sabrina Behuet, et al.
Published: (2019) -
Astrocytic-neuronal-astrocytic Pathway Selection for Formation and Degradation of Glutamate/GABA
by: Tiago B. Rodrigues
Published: (2014)